Core Viewpoint - The market anticipates a year-over-year decline in earnings for Green Plains Renewable Energy (GPRE) due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - Green Plains is expected to report a quarterly loss of $0.09 per share, reflecting a year-over-year change of -125.7%. Revenues are projected to be $548.25 million, down 16.8% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a stable outlook from covering analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows that the Most Accurate Estimate for Green Plains is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +100.00%. This suggests a bullish sentiment among analysts regarding the company's earnings prospects [11]. Historical Performance - In the last reported quarter, Green Plains was expected to post a loss of $0.28 per share but actually reported a loss of -$0.41, resulting in a surprise of -46.43%. Over the last four quarters, the company has only beaten consensus EPS estimates once [12][13]. Investment Considerations - While Green Plains is seen as a potential earnings-beat candidate, investors are advised to consider other factors that may influence stock performance beyond just earnings results [14][16].

Core Insights - Kenvue Inc. is a consumer health company with a market cap of $28.7 billion, operating in various segments including Self Care, Skin Health and Beauty, and Essential Health, and owns well-known brands like Listerine and Tylenol [1] Financial Performance - Kenvue is expected to report an adjusted EPS of $0.27 for Q3, a decrease of 3.6% from $0.28 in the same quarter last year, but has a strong history of meeting or exceeding earnings estimates [2] - For fiscal 2025, Kenvue's adjusted EPS is projected to be $0.99, down 13.2% from $1.14 in 2024, with a rebound expected in fiscal 2026 to $1.12 per share, reflecting a 13.1% year-over-year increase [3] Stock Performance - Kenvue's stock has declined by 33.8% over the past 52 weeks, significantly underperforming the Consumer Staples Select Sector SPDR Fund's 2.8% dip and the S&P 500 Index's 14.5% gain during the same period [4] - Following the release of mixed Q2 results, Kenvue's stock gained 1.5%, despite a 4.2% drop in organic sales and an overall topline decline of 4% year-over-year to $3.8 billion, which missed expectations [5] Analyst Sentiment - Analysts maintain a consensus "Moderate Buy" rating for Kenvue, with six "Strong Buys," nine "Holds," and one "Strong Sell" among 16 analysts, and a mean price target of $20.36 indicating a 34% upside potential from current levels [6]

Core Insights - NVR, Inc. is a prominent player in the homebuilding and mortgage banking industry, focusing on single-family homes, townhomes, and condominiums in the United States [1] Financial Performance - For Q3 2025, NVR reported earnings per share (EPS) of $112.33, exceeding the estimated $104.27 and the consensus estimate of $107.88, although this represents a decline from $130.50 in the same quarter last year [2] - NVR's revenue for Q3 2025 was approximately $2.61 billion, surpassing the estimated $2.43 billion, but down from $2.73 billion in the same period of the previous year [3] - The company's net income for Q3 2025 was $342.7 million, translating to $112.33 per diluted share, marking a 20% decline in net income and a 14% decrease in diluted EPS compared to Q3 2024 [4] - For the first nine months of 2025, NVR's consolidated revenues totaled $7.61 billion, reflecting a 1% decrease from the previous year [3][4] Financial Ratios - NVR maintains a price-to-earnings (P/E) ratio of approximately 14.93, indicating the market's valuation of the company's earnings [5] - The company's debt-to-equity ratio is low at 0.27, reflecting a conservative approach to leveraging [5] - NVR's current ratio is approximately 3.79, highlighting its strong liquidity position to meet short-term obligations [5]

Core Insights - QCR Holdings reported quarterly earnings of $2.17 per share, exceeding the Zacks Consensus Estimate of $1.73 per share, and showing an increase from $1.78 per share a year ago, resulting in an earnings surprise of +25.43% [1] - The company achieved revenues of $101.45 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 11.79% and up from $86.88 million year-over-year [2] - QCR Holdings has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.76 on revenues of $93.5 million, while for the current fiscal year, the estimate is $6.75 on revenues of $346.55 million [7] - The estimate revisions trend for QCR Holdings was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Banks - Midwest industry, to which QCR Holdings belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a favorable outlook for stocks within this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Viewpoint - First Bancorp reported quarterly earnings of $1.01 per share, exceeding the Zacks Consensus Estimate of $0.93 per share, and showing a year-over-year increase from $0.70 per share [1][2] Financial Performance - The company achieved revenues of $117.52 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.58%, compared to $96.62 million in the same quarter last year [2] - Over the last four quarters, First Bancorp has consistently exceeded consensus EPS estimates [2] Stock Performance - First Bancorp shares have increased approximately 11% since the beginning of the year, while the S&P 500 has gained 14.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.94 on revenues of $114.07 million, and for the current fiscal year, it is $3.54 on revenues of $443.6 million [7] - The trend of earnings estimate revisions is mixed ahead of the earnings release, which may influence future stock movements [6][5] Industry Context - The Banks - Southeast industry, to which First Bancorp belongs, is currently ranked in the top 26% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Core Insights - SEI Investments (SEIC) reported quarterly earnings of $1.3 per share, exceeding the Zacks Consensus Estimate of $1.25 per share, and showing an increase from $1.19 per share a year ago, resulting in an earnings surprise of +4.00% [1] - The company posted revenues of $578.51 million for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.17%, but up from $537.4 million year-over-year [2] - SEI has surpassed consensus EPS estimates three times over the last four quarters and has topped consensus revenue estimates two times in the same period [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.34, with expected revenues of $594.17 million, and for the current fiscal year, the EPS estimate is $5.52 on revenues of $2.28 billion [7] - The estimate revisions trend for SEI was favorable ahead of the earnings release, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Financial - Investment Management industry, to which SEI belongs, is currently in the top 20% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Market Overview - Pre-market futures are showing a flat trend with a slight downward bias following a record closing high for the Dow on Tuesday [1] - The Dow is down 9 points, S&P 500 is up 3 points, Nasdaq is down 38 points, and Russell 2000 is down 9 points at this hour [1] Federal Reserve Insights - Fed Governor Michael Barr is scheduled to make appearances ahead of the upcoming monetary policy decision from the FOMC [2] - Analysts are nearly unanimous in expecting a 25 basis-point rate cut next Wednesday, which would lower the Fed funds rate to a range of 3.75-4.00% [2] Q3 Earnings Reports - **AT&T (T)**: Reported Q3 earnings of 54 cents per share, missing estimates by 1 cent, with revenues of $30.71 billion, down 0.81% from estimates. Shares are down 1.6% [3] - **Thermo Fisher (TMO)**: Reported earnings of $5.79 per share, beating estimates of $5.50, with revenues of $11.12 billion, exceeding expectations by 2%. Shares are up 2% [4] - **GE Vernova (GEV)**: Reported earnings of $1.64 per share, missing the consensus of $1.78 by 7.87%, but revenues of $9.97 billion were 8.62% higher than anticipated. Shares are up 3.8% [5] - **Teck Resources (TECK)**: Reported earnings of 55 cents per share, surpassing projections by 41%, with revenues of $2.46 billion, exceeding consensus by 14.3%. This company may gain relevance due to rare earth negotiations with China [6] Upcoming Earnings Expectations - **Tesla (TSLA)**: Expected to report negative earnings per share, down 26.4% year over year, but with a 5% increase in revenues. Shares are up 9.6% year to date [7] - **IBM**: Anticipated to report earnings 6% higher and revenues up 7.57% for the quarter, with shares having gained 28% since the start of the year [9] - **Southwest Airlines (LUV)**: Facing a tough year-over-year comparison with expected earnings growth down 93% but a slight revenue increase of 1.44% [9]

Core Viewpoint - Bausch Health (BHC) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending September 2025, with actual results being crucial for near-term stock price movements [1][2]. Earnings Expectations - The upcoming earnings report is scheduled for October 29, and better-than-expected key numbers could lead to a stock price increase, while a miss could result in a decline [2]. - The consensus estimate for quarterly earnings is $1.07 per share, reflecting a year-over-year decrease of 4.5%, while revenues are projected to be $2.6 billion, up 3.8% from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 7.76%, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Bausch is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +7.73%, suggesting a bullish outlook from analysts [12]. Historical Performance - In the last reported quarter, Bausch was expected to post earnings of $0.97 per share but delivered $0.90, resulting in a surprise of -7.22% [13]. - Over the past four quarters, Bausch has beaten consensus EPS estimates twice [14]. Predictive Indicators - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy) or 2 (Buy) [10]. - Bausch currently holds a Zacks Rank of 2, indicating a higher likelihood of beating the consensus EPS estimate [12].

Core Viewpoint - The market anticipates Caterpillar (CAT) will report a year-over-year decline in earnings despite an increase in revenues for the quarter ending September 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Caterpillar is expected to post quarterly earnings of $4.52 per share, reflecting a year-over-year decrease of 12.6%, while revenues are projected to reach $16.75 billion, a 4% increase from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 0.44% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a positive Earnings ESP of +1.44% for Caterpillar, suggesting recent bullish sentiment among analysts, although the stock holds a Zacks Rank of 4, complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, Caterpillar was expected to earn $4.88 per share but only achieved $4.72, resulting in a surprise of -3.28%. Over the past four quarters, the company has only beaten consensus EPS estimates once [13][14]. Conclusion - While Caterpillar may not be a strong candidate for an earnings beat, investors should consider other factors influencing stock performance ahead of the earnings release [17].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Bio-Rad Laboratories, with a focus on how actual results compare to estimates, which could significantly impact stock price [1][2]. Earnings Expectations - Bio-Rad is expected to report quarterly earnings of $2.30 per share, reflecting a year-over-year increase of 14.4%. Revenues are projected to be $651.42 million, up 0.3% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their initial estimates during this period [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate matches the Zacks Consensus Estimate for Bio-Rad, resulting in an Earnings ESP of 0%. The stock currently holds a Zacks Rank of 4, complicating predictions for an earnings beat [12]. Historical Performance - In the last reported quarter, Bio-Rad exceeded expectations by posting earnings of $2.61 per share against an expected $1.93, achieving a surprise of 35.23%. Over the last four quarters, the company has beaten consensus EPS estimates three times [13][14]. Conclusion - While Bio-Rad does not appear to be a strong candidate for an earnings beat, investors should consider other factors when making decisions regarding the stock ahead of the earnings release [17].